Search Results

NHS must do more to prevent patient harm

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 5-5(1)

Publisher: Adis International

Specific health risks result in millions of deaths

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 591, 2009-11-14 , pp. 9-9(1)

Publisher: Adis International

British consumers are predicted to pay £521 million for over-the-counter (OTC) cold/flu remedies

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 591, 2009-11-14 , pp. 9-9(1)

Publisher: Adis International

Pazopanib has been added to the Clinical Practice Guidelines in Oncology for Kidney Cancer, following its US FDA approval last month.

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 591, 2009-11-14 , pp. 9-9(1)

Publisher: Adis International

Revised Canadian lipid management guidelines

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 591, 2009-11-14 , pp. 10-10(1)

Publisher: Adis International

The position of the Australian Pharmaceutical Benefit Scheme (PBS) looks to be stable

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 591, 2009-11-14 , pp. 14-14(1)

Publisher: Adis International

Biosimilars of tumour necrosis factor-α (TNF-α) inhibitors will erode $9.6 billion in brand sales

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 591, 2009-11-14 , pp. 14-14(1)

Publisher: Adis International

Gastric cancer drug market to grow through targeted therapies

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 591, 2009-11-14 , pp. 14-14(1)

Publisher: Adis International

Decision Resources predicts that the bipolar disorder drug market will decline by more than $US1 billion over the next decade.

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 591, 2009-11-14 , pp. 14-14(1)

Publisher: Adis International

US FDA announces launch of Safe Use Initiative

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 1-1(1)

Publisher: Adis International

Prevnar batch suspended after three infant deaths

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 2-2(1)

Publisher: Adis International

Hospira have voluntarily recalled certain lots of propofol and Liposyn [soya oil emulsion]

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 2-2(1)

Publisher: Adis International

Body building dietary supplements found to contain steroids

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 4-4(1)

Publisher: Adis International

A `dietary supplement' marketed for sexual enhancement has been found to illegally contain an undeclared pharmaceutical agent

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 4-4(1)

Publisher: Adis International

Certain lots of Tylenol [paracetamol, acetaminophen] Arthritis Pain Caplets are being voluntarily recalled in the US.

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 4-4(1)

Publisher: Adis International

Progress in global access to HIV/AIDS interventions

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 589, 2009-10-17 , pp. 2-2(1)

Publisher: Adis International

Patients may be safely vaccinated even after allergic reactions

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 589, 2009-10-17 , pp. 2-2(1)

Publisher: Adis International

Nearly one-fifth of eligible cancer patients in the US fail to receive Avastin [bevacizumab] due to its high cost

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 589, 2009-10-17 , pp. 8-8(1)

Publisher: Adis International

Prescriptions for psychotropic drugs are mostly written by general practitioners (GPs)

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 589, 2009-10-17 , pp. 9-9(1)

Publisher: Adis International

The breast cancer drug market in China is expected to grow from $165 million in 2008 to $298 million in 2013

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 589, 2009-10-17 , pp. 11-11(1)

Publisher: Adis International